News
OrisDX on-stage at HLTH 2024 as Finalist for Digital Health Awards
Digital Health Hub Foundation
October 2024
OrisDX to be featured at ADA Forsyth’s Technology Showcase as Innovation Finalist
American Dental Association Forsyth Institute
September 2024
OrisDX named a Digital Health Quarterfinalist for Emerging Innovation in Dental Health
Digital Health Hub Foundation
August 2024
OrisDX on-stage at Polsky Deep Tech Ventures Summit 2024
Polsky Center for Entrepreneurship and Innovation
June 2024
OrisDX Graduates from CDL-Cancer Inaugural Cohort
Creative Destruction Lab
June 2024
OrisDX unveils oral cancer + HPV dual assay at ASCO 2024
ASCO
May 2024
Oral cancer diagnostic aid optimized at University of Chicago Medical Center
OrisDX
February 2024
OrisDX at HLTH in first ever oral health pavilion
HLTH
October 2023
OrisDX selected to join CDL-Cancer Inaugural Cohort
Creative Destruction Lab
October 2023
Seasoned executive Harald Steltzer tapped as CEO
OrisDX
September 2023
23 Startups to watch in 2023
CHICAGOINNO
July 2023
OrisDX highlighted as innovative startup at NextMed 2023
NextMed
March 2023
OrisDX expands team naming industry experts to Advisory Board
OrisDX
February 2023
George Schultz Innovation Fund co-investment to further develop OrisDX technologies
Polsky Center for Entrepreneurship and Innovation
July 2022
OrisDX Wins 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers
Polsky Center for Entrepreneurship and Innovation
June 2022
Ultra-sensative detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma
Cancer
May 2021